← Open Payments lookup

RONALD GARB: Open Payments

NPI 1891776167 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,964 in 95 payments from 17 companies in 2025. Trend: 2023 $1,319 · 2024 $1,709 · 2025 $1,964

Food & beverage: $1,944Education: $19
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$333
Neurocrine BioSciences, Inc.9$232
Teva Pharmaceuticals USA, Inc.13$218
Otsuka America Pharmaceutical, Inc.11$202
Corium, LLC6$180
ABBVIE INC.11$156
Alkermes, Inc.5$109
Axsome Therapeutics, Inc.5$101
Takeda Pharmaceuticals U.S.A., Inc.3$65
Vanda Pharmaceuticals Inc.3$61

Products named: CAPLYTA, INGREZZA, REXULTI, Azstarys, AUSTEDO XR, VRAYLAR, ARISTADA, Auvelity.

Industry payments across TX — which companies pay providers there.